Gladius Capital Management’s Biote Corp BTMD Stock Holding History

Gladius Capital Management’s Portfolio BTMD Stock Details BTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-8,645	Closed	-$50.1K	–	312
2024 Q1	$50.1K	Buy	+8,645	New	+$43.3K	0.02%	175

Other funds holding BTMD

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

Bandera Partners New York $221M AUM 10.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIM

SW Investment Management Telluride, Colorado $451M AUM 79.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Gladius Capital Management's BTMD Position: Q2 2024 in Review

Gladius Capital Management sold out of Biote Corp (BTMD) in Q2 2024, closing a stake of 8,645 shares — an estimated $50.1K sold.

Gladius Capital Management first reported a position in BTMD in Q1 2024 and held it in 1 quarter. The position peaked at $50.1K in Q1 2024. 75 funds tracked by Wall St. Rank hold BTMD as of Q2 2024.

Gladius Capital Management reported no remaining Biote Corp position as of Q2 2024 after selling out during the quarter.
Gladius Capital Management sold 8,645 Biote Corp shares in Q2 2024, an estimated $50.1K.
Gladius Capital Management first reported a position in Biote Corp in Q1 2024 and held it in 1 quarter.
Gladius Capital Management's Biote Corp position peaked at $50.1K in Q1 2024.
75 funds tracked by Wall St. Rank held Biote Corp as of Q2 2024.

Based on Gladius Capital Management's 13F filing for Q2 2024, filed 18 Jul 2024.